Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

How GSK, Chiesi Farmaceutici, Regeneron/Sanofi...

ATS 2020 Virtual is happening from August 5 to August 10, and it is exciting to watch major Respiratory Pharmaceutical companies and their key presentations. GlaxoSmithKline's Trelegy Ellipta for t...

Aug 13, 2020

most-deadly-Infectious-diseases-in-the-world
Infectious Diseases That Possess Significant Challenge To Humans Health

Infectious diseases or communicable diseases are one of the leading causes of death worldwide. These diseases are spread by pathogenic microorganisms, such as bacteria, viruses, parasites, or fungi. Infectious diseases possess greater risk as these diseases can easily transfer from human to human or by other modes....

Find More
Delveinsight
Boehringer Ingelheim; Roche demonstrated new analyses of their drugs in patients with ILDs during the American Thoracic Society (ATS) Virtual conference

ATS 2020 Virtual is scheduled to be held from August 5 to August 10, and it is exciting to watch the key presentations by Pharmaceutical Companies specifically focused on pulmonary disease, critical illness, and sleep disorders. Boehringer Ingelheim presented new analyses of Ofev data in patients with chronic fi...

Find More
Delveinsight
Merck; Bayer; Shionogi set to showcase their candidates indicated for Chronic RefractoryCough in the ATS Virtual Conference

Merck’s Gefapixant could become the first drug approved for Chronic Cough ATS 2020 Virtual is happening from August 5 to August 10, and it is exciting to watch major Respiratory /Pulmonary Pharmaceutical companies and their key presentations. Merck is worth mentioning here, as it is presenting key posters and...

Find More

More Views & Analysis

Medical Marijuana Market | Medical Cannabis Market
Medical Marijuana: Is it a blessing in disguise or a curse for humanity?

The influx of companies, the launch of pipeline therapies, and the legalization of marijuana/ cannabis are the major drivers of the medical marijuana market. Cannabis, popularly known as Marijuana, is the most commonly used illicit drug after alcohol. More than 150 Million people regularly smoke marijuana. Appr...

Find More

Hereditary Transthyretin Amyloidosis Market | hATTR Market Size | hATTR
Unfolding The Folds Of Transthyretin

The Hereditary Transthyretin Amyloidosis (hATTR) Market size in the 7MM was estimated to be USD 306.9 Million in 2017 and is anticipated to grow further in the forecast period 2020-30 owing to recent approvals and pipeline therapies.Among the 7MM geographies, the US accounted for the 54% share of the total hATTR ma...

Find More

Cancer Cachexia Market
Enough Of Wasting Away From Cancer: Companies Gear Up To Tackle Cachexia

The dynamics of the cancer cachexia market is expected to gain momentum as several companies are testing the waters, advancing cancer cachexia pipeline. More than half of the cancer patients suffer from cachexia, and over 30% of the cancer patients succumb to death due to complications that arise from cachexi...

Find More

Adrenoleukodystrophy Market | ALD Market
A Complex Chromosomal Abberation Called Adrenoleukodystrophy

The global Adrenoleukodystrophy market size for the forecast period 2020-30, which was estimated to be USD 922.43 million in the 7MM in 2017 is driven by key pharma players such as Bluebird Bio, Minoryx Therapeutics, MedDay Pharmaceuticals, Magenta Therapeutics, and others are proactively focusing on advancing ALD ...

Find More

Frontotemporal-dementia-market
Addressing The Scattered Harbingers of Frontotemporal Dementia

The Frontotemporal dementia market is expected to increase with a CAGR of 21.41% for 7MM during the study period. However, pharma companies such as TauRx Therapeutics, Axon Neuroscience SE, Prevail Therapeutics, Avid Radiopharmaceuticals, and Alector are actively working to buildup the Frontotemporal dementia pipel...

Find More

Familial Chylomicronemia Syndrome Market
Rejections and Withdrawals: Familial Chylomicronemia Syndrome Market Needs a Therapy sufficiently Effective, sufficiently Affordable

A rare autosomal recessive disorder, Familial chylomicronemia syndrome (FCS) affects 1 in 1 to 2 million people (Burnett and Hegele, 1999; Pouwels et al. 2008). As per DelveInsight, the total Familial chylomicronemia syndrome diagnosed prevalent population in the 7MM [the US, EU4 (Germany, Franc...

Find More

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive form of interstitial lung disease (ILD.....

Find More

Alopecia Areata (AA) is an autoimmune disorder that leads to hair loss on the scalp, face, and on ot.....

Find More

Remdesivir is a broad-spectrum antiviral drug that has previously demonstrated in vitro and in vivo .....

Find More

Immune thrombocytopenic purpura (ITP) is a disorder that results in the immune system killing its pl.....

Find More

Developmental and Epileptic Encephalopathy (DEE) refers to a group of severe epilepsies that are cha.....

Find More

Diabetic macular edema (DME) is an eye disease in which there is fluid buildup in the macula. Even t.....

Find More